The Punch on MSN
The renewed focus on rubella
The increase in concern about rubella in Nigeria is not due to a brand-new outbreak, but rather the alarming convergence of long-standing low vaccination coverage, recent major outbreaks, and the ...
Healthbeat on MSN
How new weight-loss drugs may offer hope for curbing addiction
Scientists don’t yet fully understand how GLP-1 drugs like Ozempic affect the brain’s reward pathways, but there are ...
Everyday Health on MSN
Living with bronchiectasis: 8 tips to reduce flare-ups and infections
Manage bronchiectasis effectively with these practical lifestyle tips that can help reduce flare-ups, prevent infections, and keep your lungs clear.
As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well. It had one of its worst effectiveness rates in more than a decade.
MedPage Today on MSN
CDC Studies Suggest Slumping Flu Shot Protection
Viral mismatch between circulating strains and vaccine may have weighed down effectiveness ...
Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
Health experts are warning that the 2025-26 flu season isn't over yet. In fact, people should prepare for the virus to linger well into the warmer months, according to Dr. Michael Glazier, chief ...
Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
DALLAS — In the last few weeks, there’s been an uptick in flu and norovirus cases across the country, and North Texas is feeling the impact. Eagle Mountain-Saginaw ISD’s Creekview Middle School in ...
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...
The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...
For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results